Dr. Centor discusses the use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists and the risk for cardiovascular outcomes in routine care patients with diabetes with Dr. Elisabetta Patorno.

SGLT2 vs GLP1 for Cardiovascular Prevention

Each Annals On Call podcast features Dr. Bob Centor discussing and debating a clinically influential article published in Annals of Internal Medicine with a guest expert.

Medicine

Science & Medicine

Health & Fitness

Dr. Centor discusses the adverse events associated with checkpoint inhibitors with Drs. Reaford Blackburn Jr. and Brian C. Westbrook.

Checkpoint Inhibitors: What Generalists Need to Know

Dr. Centor discusses how to go beyond statistical significance testing when interpreting study findings with Dr. David Savitz.

Improving Research Reports: Avoiding p-Values

Dr. Centor discusses the real-world complications of lung cancer screening with Drs. Katharine A. Rendle and Anil Vachani.

Real World Complications of Lung Cancer Screening

Dr. Centor discusses the association between gabapentinoids and chronic obstructive pulmonary disease with Mr. Rahman and Dr. Renoux.

Gabapentinoids and COPD: Not a Good Mix?

Dr. Centor discusses encouraging patients to receive influenza vaccination with Drs. Mark Tenforde and Fatimah Dawood.

SGLT2 vs GLP1 for Cardiovascular Prevention

Download our free app to listen on your phone